Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shunji Takahashi

Showing results (1-10 of 412) with videos related to

Pageof 42
Sort By:
Clinical Calcium|September 1, 2015
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with sex hormone depletion treatment]Shunji Takahashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
[Molecular Target Therapy for Soft Tissue Sarcoma]Shunji Takahashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Management of adverse events with interferon and interleukin-2]Shunji Takahashi
Clinical Calcium|March 2, 2011
[Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL]Shunji Takahashi
Clinical Calcium|August 5, 2011
[ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)]Shunji Takahashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 14, 2012
[Anti-RANKL antibody for treatment of patients with bone metastasis from breast cancer]Shunji Takahashi
Clinical Calcium|March 1, 2013
[Bone metabolic markers for evaluation of bone metastases]Shunji Takahashi
Expert Opinion on Drug Safety|August 31, 2021
Fatigue and its management in cancer patients undergoing VEGFR-TKI therapyShunji Takahashi
Clinical Calcium|July 29, 2014
[Strategy of therapy for bone metastases of cancer]Shunji Takahashi
Journal of Bone and Mineral Metabolism|April 10, 2023
Management of cancer treatment-induced bone loss (CTIBL) in patients with breast cancer or prostate cancerShunji Takahashi
Pageof 42

Showing results (1-10 of 412) with videos related to

Sort By:
Pageof 42
Clinical Calcium|September 1, 2015
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Osteoporosis associated with sex hormone depletion treatment]Shunji Takahashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
[Molecular Target Therapy for Soft Tissue Sarcoma]Shunji Takahashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 3, 2015
[Management of adverse events with interferon and interleukin-2]Shunji Takahashi
Clinical Calcium|March 2, 2011
[Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL]Shunji Takahashi
Clinical Calcium|August 5, 2011
[ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)]Shunji Takahashi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 14, 2012
[Anti-RANKL antibody for treatment of patients with bone metastasis from breast cancer]Shunji Takahashi
Clinical Calcium|March 1, 2013
[Bone metabolic markers for evaluation of bone metastases]Shunji Takahashi
Expert Opinion on Drug Safety|August 31, 2021
Fatigue and its management in cancer patients undergoing VEGFR-TKI therapyShunji Takahashi
Clinical Calcium|July 29, 2014
[Strategy of therapy for bone metastases of cancer]Shunji Takahashi
Journal of Bone and Mineral Metabolism|April 10, 2023
Management of cancer treatment-induced bone loss (CTIBL) in patients with breast cancer or prostate cancerShunji Takahashi
Pageof 42